![James Healy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 110 M $ al 31/08/2026
Currently, James Irvin Healy is Director at Sorbent Therapeutics, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., and Atsena Therapeutics, Inc. He serves as Independent Director at Arrivent BioPharma, Inc. (since 2023), Rapport Therapeutics, Inc. (since 2023), BioAge Labs, Inc. (since 2024), and Seaport Therapeutics, Inc. (since 2024).
He is General Partner at Sofinnova Venture Partners VII LP and Managing Partner at Sofinnova Investments, Inc. (since 2000), Sofinnova Management VI LLC, Sofinnova Management VII LLC (since 2012), and Sofinnova Investments, Inc. (Investment Management) (since 2000).
Formerly, he was Chairman at Hyperion Therapeutics, Inc. (2012–2015) and Y-mAbs Therapeutics, Inc. (2022–2025).
He was Vice Chairman at Auris Medical AG and Auris Medical Holding AG.
He served as Independent Non-Executive Director at Amarin Corp.
Plc (2012–2016), Independent Director at InterMune, Inc. (2011–2014), Anthera Pharmaceuticals, Inc. (2011–2014), Edge Therapeutics, Inc. (2015–2018), Ascendis Pharma A (2014–2022), NuCana Plc (2014–2022), Coherus Oncology, Inc. (2014–2022), Iterum Therapeutics Plc (2015–2020), and Natera, Inc. (2014–2025).
He was Director at CoTherix, Inc. (2001–2007), Novacea, Inc. (2001–2009), Movetis NV (2007–2010), PregLem SA (2009–2010), ObsEva SA (2013–2021), CinCor Pharma, Inc. (2019–2023), and others.
He was Lead Independent Director at Bolt Biotherapeutics, Inc. (2021–2024) and Independent Director at Karuna Therapeutics, Inc. (2019–2024).
Earlier roles include Manager at ISTA Pharmaceuticals, Inc. (1997–1998) and Associate at Sanderling Management CO LLC (1996).
Education includes undergraduate degree from the University of California, Berkeley (1990) and doctorate from Stanford University School of Medicine and Stanford University (1998).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 1.947.579 ( 4,06 % ) | 95 M $ | 31/08/2026 | |
NATERA, INC. 0,03 % | 25/04/2025 | 46.260 ( 0,03 % ) | 15 M $ | 31/08/2026 |
BIOAGE LABS, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Director/Miembro de la Junta | 01/03/2023 |
| RAPPORT THERAPEUTICS, INC. | Director/Miembro de la Junta | 23/08/2023 |
| BIOAGE LABS, INC. | Director/Miembro de la Junta | 01/02/2024 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Inversor de Capital Privado | 01/06/2000 |
Sofinnova Venture Partners VII LP
 Sofinnova Venture Partners VII LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Director/Miembro de la Junta | - |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Miembro de la Junta | - |
Sofinnova Investments, Inc. (Investment Management)
 Sofinnova Investments, Inc. (Investment Management) Investment ManagersFinance Sofinnova-IM primary focuses on (i) private venture related investments or (ii) equity related investments in public securities. Investments are generally made in biotechnology, pharmaceuticals and related industries. For its Venture Funds, the firm seeks to build a diverse and risk mitigated portfolio across stage, geography and equity market exposure. For its Public Fund, Sofinnova-IM seeks to deliver absolute returns across market cycles with the goal of capitalizing on significant sector inefficiency in the Therapeutics industry while exercising valuation discipline and focusing on risk management. | Director Ejecutivo | 01/06/2000 |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Director/Miembro de la Junta | - |
| ░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 54 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets ophthalmic pharmaceutical products | Health Technology |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Ventures invests in companies located in the United States. The firm participates in seed and early-stage capital transactions. It focuses on sectors such as biomedical and emerging technology. | Finance |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Bayer Pharmaceuticals Corp. | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Health Technology |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Sofinnova Venture Partners VII LP
Sofinnova Venture Partners VII LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Salveo Specialty Pharmacy, Inc.
 Salveo Specialty Pharmacy, Inc. Medical/Nursing ServicesHealth Services Provides medications and clinical services | Health Services |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cellective Therapeutics, Inc.
 Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provides biopharmaceutical products | Health Technology |
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Researches on environmental studies, nanoscience and quantitative biology, physics and nuclear energy | Commercial Services |
Sofinnova Management VI LLC | |
Sofinnova Management VII LLC | |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Specializes in developing compounds for gastrointestinal disorders | Health Technology |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Health Technology |
Natera, Inc.
 Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auris Medical Holding AG /Old/
 Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Sofinnova Investments, Inc. (Investment Management)
Sofinnova Investments, Inc. (Investment Management) Investment ManagersFinance Sofinnova-IM primary focuses on (i) private venture related investments or (ii) equity related investments in public securities. Investments are generally made in biotechnology, pharmaceuticals and related industries. For its Venture Funds, the firm seeks to build a diverse and risk mitigated portfolio across stage, geography and equity market exposure. For its Public Fund, Sofinnova-IM seeks to deliver absolute returns across market cycles with the goal of capitalizing on significant sector inefficiency in the Therapeutics industry while exercising valuation discipline and focusing on risk management. | Finance |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
